Regardless of the mechanism, reducing hypoglycaemia on BI treatment in T2DM is an important goal to improve long‐term adherence of patients to insulin treatment and titration to target, as demonstrated by the high retention of patients in ITAS in both groups for the entire duration of the study. Here, INS is linked to type 2 diabetes mellitus.